Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences
About this trial
This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.
Eligibility criteria
Qualifiers
18-75 years;
Patients underwent laparoscopic and thoracoscopic or robotic-assisted minimally invasive esophagectomy ;
Informed consent.
Disqualifiers
Has a history of cholecystitis or urolithiasis within 3 months;
Has a history of atherothrombosis (peripheral arterial disease), stroke, myocardial infarction;
With lung diseases, such as pneumonia, atelectasis, emphysema, pulmonary bullae, etc;
Preoperative cardiac function grade ≥ III or coronary artery stenosis;
Trial design
Treatments tested in this trial
- Preemptive flurbiprofen axetil
- Postoperative flurbiprofen axetil
- Patient-controlled analgesia pump
Treatment groups
102 Participants
are divided into 3 treatment groupsLocations
1Cancer Hospital Chinese Academy of Medical Sciences Beijing China
Sponsors and collaborators
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Lead sponsor
Source ClinicalTrials.gov